Preventing cervical cancer and genital warts–How much protection is enough for HPV vaccines?
M Stanley - Journal of Infection, 2016 - Elsevier
HPV associated disease is a global health problem: 5.2% of all cancers are HPV associated
with HPV 16 and 18 accounting for 70% of cases of cervical cancer. Genital warts caused by …
with HPV 16 and 18 accounting for 70% of cases of cervical cancer. Genital warts caused by …
Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related disease in females and males
H Bergman, BS Buckley, G Villanueva… - Cochrane database …, 1996 - cochranelibrary.com
Background Uptake of human papillomavirus (HPV) vaccine remains low in many countries,
although the bivalent and quadrivalent HPV vaccines given as a three‐dose schedule are …
although the bivalent and quadrivalent HPV vaccines given as a three‐dose schedule are …
Human papillomavirus disease and vaccines
DJ Hutchinson, KC Klein - American Journal of Health-System …, 2008 - academic.oup.com
Purpose. Human papillomavirus (HPV) disease and vaccines and several controversial
issues associated with vaccine administration are reviewed. Summary. HPV infection is the …
issues associated with vaccine administration are reviewed. Summary. HPV infection is the …
HPV vaccine and males: issues and challenges
GD Zimet, SL Rosenthal - Gynecologic oncology, 2010 - Elsevier
The quadrivalent vaccine has been shown to be safe and efficacious against HPV infection
in men. It is expected, though, that male vaccination rates will remain low. Therefore this …
in men. It is expected, though, that male vaccination rates will remain low. Therefore this …
Two vs three doses of human papillomavirus vaccine: New policy for the second decade of the vaccination program
LE Markowitz, E Meites, ER Unger - Jama, 2016 - jamanetwork.com
(HPV) vaccination program in the United States. In 2006, the first HPV vaccine, quadrivalent
HPV vaccine, was licensed by the US Food and Drug Administration and recommended by …
HPV vaccine, was licensed by the US Food and Drug Administration and recommended by …
Human papillomavirus infections: diagnosis, treatment, and hope for a vaccine
KA Ault - Obstetrics and Gynecology Clinics, 2003 - obgyn.theclinics.com
Human papillomavirus (HPV) is perhaps the most common sexually transmitted infection in
the United States. There are 5.5 million new cases of HPV every year, and approximately 20 …
the United States. There are 5.5 million new cases of HPV every year, and approximately 20 …
Human papillomavirus vaccine introduction–the first five years
LE Markowitz, V Tsu, SL Deeks, H Cubie, SA Wang… - Vaccine, 2012 - Elsevier
The availability of prophylactic human papillomavirus (HPV) vaccines has provided powerful
tools for primary prevention of cervical cancer and other HPV-associated diseases. Since …
tools for primary prevention of cervical cancer and other HPV-associated diseases. Since …
Population effectiveness, not efficacy, should decide who gets vaccinated against human papillomavirus via publicly funded programs
PE Castle, FH Zhao - Journal of Infectious Diseases, 2011 - academic.oup.com
Persistent infections by carcinogenic or high-risk genotypes of human papillomavirus (HPV)
have been proved to be the cause of virtually all cervical cancer and are also associated …
have been proved to be the cause of virtually all cervical cancer and are also associated …
Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine
SM Garland, M Steben, HL Sings… - The Journal of …, 2009 - academic.oup.com
Background The placebo arm of human papillomavirus (HPV) vaccine trials helps define the
natural history of genital warts (GW) Methods Women enrolled in the placebo arm (n= 8800) …
natural history of genital warts (GW) Methods Women enrolled in the placebo arm (n= 8800) …
Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males
AR Giuliano, JM Palefsky, S Goldstone… - … England Journal of …, 2011 - Mass Medical Soc
Background Infection with human papillomavirus (HPV) and diseases caused by HPV are
common in boys and men. We report on the safety of a quadrivalent vaccine (active against …
common in boys and men. We report on the safety of a quadrivalent vaccine (active against …